Paul Loebach, Branch Chief for the Drug Registration and Listing Branch (DRLB), delivers his closing remarks to the “eDRLS Using CDER Direct” Conference and engages with the audience in a question-and-answer panel.

Additional presenters, from the Office of Compliance’s Drug Registration and Listing Branch (OC|DRLB) (unless otherwise mentioned), and presentations include:

Registration and Listing Deficiency Letters
Tasneem Hussian, PharmD

Current Compliance Projects: U.S. Agents – Verification Initiative & Listing Inactivation Project
Leyla Rahjou-Esfandiary
Paul Loebach

Submission Troubleshooting Exercise
Julian Chun, PharmD

Q&A Panel (Including all above presenters):
Capt. Matt Brancazio, Office of Management’s Division of User Fee Management
Troy Cu

For slides and additional information: [ Ссылка ]
-------------------- 
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
 
Upcoming Training - [ Ссылка ]
SBIA Listserv - [ Ссылка ]
SBIA 2021 Playlist - [ Ссылка ]
SBIA LinkedIn - [ Ссылка ]
SBIA Training Resources - [ Ссылка ]
Twitter - [ Ссылка ]
Email - CDERSBIA@fda.hhs.gov
Phone - (301) 796-6707 I (866) 405-5367

свернуть